ArticleCancer biology & medicine2025
Impact of pre-neoadjuvant radioactive iodine seed marking on pathologic complete response and survival in early-stage breast cancer patients.
Yihao Geng, Qi Zhang, Zhao Bi, Zhiqiang Shi, Qiuchen Zhao, Xiaowei Qi, Rongrong Zhao, Yongsheng Wang, Pengfei Qiu
Abstract readLetter
In one paragraphArticle in Cancer biology & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Yihao Geng *Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Qi Zhang *Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Zhao Bi *Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Zhiqiang ShiBreast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Qiuchen ZhaoCancer Research UK Cambridge Centre and Department of Oncology, University of Cambridge, Cambridge CB2 0XZ, UK.
Xiaowei QiDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University, Chongqing 400038, China.
Rongrong ZhaoBreast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.ORCID 0009-0006-8721-8986 Yongsheng WangBreast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.ORCID 0009-0002-1134-1815 Pengfei QiuBreast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.ORCID 0000-0001-6784-410X Funding
Collaborative Academic Innovation Project of Shandong Cancer Hospital GF003National Natural Science Foundation of China 82172873National Natural Science Foundation of China 82503888National Natural Science Foundation of China 82573747National Natural Science Foundation of China W2421095National Science and Technology Major Project 2025ZD0543900Natural Science Foundation of Shandong Province ZR2024LMB011Natural Science Foundation of Shandong Province ZR2024QH058Taishan Scholars Program of Shandong Province tsqn202211337
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID41454490
PMCPMC12911431
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390